J Rosenstock, SL Schwartz, CM Clark, GD … - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—The treatment groups showed similar improvements in HbA 1c from
baseline to end point on intent-to-treat analysis. The mean change (means ± SD)
in HbA 1c from baseline to end point was similar in the insulin glargine ... Cited by 30 - Related articles - All 2 versions
- Free from Publisher J Rosenstock, SL Schwartz, CM Clark Jr, GD … - Diabetes Care, 2001 - 万方数据资源系统 OBJECTIVE: To determine the safety and efficacy of the long-acting analog
insulin glargine compared with NPH insulin in patients with type 2 diabetes who
were previously treated with insulin alone. RESEARCH DESIGN AND METHODS: A ... Cited by 345 - Related articles - BL Direct - All 5 versions
EJ Bastyr, Y Huang, RL Brunelle, L Vignati, … - Diabetes, Obesity and Metabolism, 2000 - ingentaconnect.com 1 Eli Lilly and Company, Indianapolis, IN, USA 2 Fred Hutchinson Cancer Research
Center, Seattle, WA, USA 3 University of Virginia, Health Sciences Center,
Charlottesville, VA, USA ... Aim: To identify factors associated with ... Cited by 15 - Related articles - BL Direct - All 4 versions
[CITATION] Treatment to target study: insulin glargine vs NPH insulin added to oral therapy of type 2 …
M Rodier, C Colette, C Gouzes, F Michel, AC … - Diabetes research and clinical practice, 1995 - Elsevier The effects of intensive insulin therapy on metabolic control, fatty acid
metabolism and platelet function were studied in 18 non-obese
non-insulin-dependent diabetics (NIDDs) with secondary failure to oral ... Cited by 3 - Related articles - All 5 versions
MG Wulffele, A Kooy, P Lehert, D Bets, JA … - … evidence-based versus rational pharmacotherapy 228 - njmonline.nl ABSTRACT Background: Metformin added to insulin therapy in type 2 diabetic
patients improves glycaemic control and decreases the required daily dose of
insulin (DDI). Metformin should be discontinued if cardiac, hepatic or ... Cited by 4 - Related articles - View as HTML - All 5 versions
[CITATION] Costeffectiveness of intensive insulin therapy for type 2 diabetes
R Niazi, Z Muzaffar - JPMA. The Journal of the Pakistan Medical Association, 1998 - ncbi.nlm.nih.gov OBJECTIVE: To compare the effects of bedtime NPH Insulin vs Metformin combined
with Glibenclamide in patients who are obese and had secondary failure to
sulphonylurea treatment. DESIGN AND METHODS: Prospective, randomized, ... Cited by 5 - Related articles - BL Direct - All 4 versions
[CITATION] A three-month comparison between multiple daily NPH and once daily glargine insulin …
